Squeezy vs Vademecum de medicamentos
Squeezy
Living With Ltd
App Store
$1.6K/mo
~$19.7K/yr · 12K installs
VS
Vademecum de medicamentos
Luis Ayala
App Store
$0/mo
~$0/yr · 0 installs
Revenue winner
Squeezy wins
+164300% vs other
Installs winner
Squeezy wins
+1235000% vs other
MAU winner
Squeezy wins
+319865% vs other
Rating winner
Squeezy wins
+479% vs other
Why Squeezy is winning
Top 3 reasons - backed by the public App Store / Play Store numbers.
- Squeezy earns roughly 1643× more per month than Vademecum de medicamentos - $1.6K vs $0.
- Bigger install base. Squeezy has ~12K lifetime installs vs Vademecum de medicamentos's ~0 - 12350.0× the funnel top.
- Better app store reviews. Squeezy sits at 4.79★ vs 0.00★ - store algorithms reward higher-rated apps with more impressions.
→ Find more apps with this revenue gap · Full Squeezy report
Side-by-side metrics
Bars scale to whichever app is bigger on that row. Green = winner.
Squeezy
vs
Vademecum de medicamentos
Monthly revenue (est.)?
$1.6K
◀
$0
Annual revenue (est.)
$19.7K
◀
$0
Lifetime installs (est.)
12K
◀
0
Monthly active users (est.)?
3K
◀
0
App Store rating
4.79★
◀
-
Total ratings
247
◀
0
US grossing rank
-
=
-
Cheapest monthly sub
No sub
=
No sub
IAP tiers detected
0 tiers
=
0 tiers
- Category
- Medical
- Price
- USD4.99
- Released
- Oct 14, 2014
- Last updated
- Jun 25, 2026
- File size
- 41.6 MB
- Content rating
- 12+
- Version
- 10.1.4
- Languages
- English, Polish
- Category
- Medical
- Price
- USD4.99
- Released
- Aug 26, 2022
- Last updated
- Jul 23, 2025
- File size
- 30.8 MB
- Content rating
- 17+
- Version
- 9.0
- Languages
- English
Squeezy trajectory
Vademecum de medicamentos trajectory
FAQ
Which makes more money, Squeezy or Vademecum de medicamentos? v
Squeezy earns about $1.6K per month, while Vademecum de medicamentos earns about $0. That is a ∞× revenue gap (~$1.6K more per month for Squeezy). Annual revenue: Squeezy ≈ $19.7K/year, Vademecum de medicamentos ≈ $0/year. Estimates are derived from public App Store signals - grossing rank, scraped IAP tiers, ratings and category benchmarks.
Which has more downloads, Squeezy or Vademecum de medicamentos? v
Squeezy leads with about 12K estimated downloads vs 0 for Vademecum de medicamentos - a ∞× gap. Squeezy's App Store downloads are estimated from 247 ratings × the standard 1:75 ratio. Vademecum de medicamentos's App Store downloads are estimated from 0 ratings.
Are Squeezy and Vademecum de medicamentos in the same App Store category and competing for the same money? v
Yes - both apps sit in the Medical category, which means they compete directly for the same paying users and category-level wallet share. Direct competitors, head-to-head.
Do Squeezy and Vademecum de medicamentos have in-app purchases? v
Squeezy does not appear to offer in-app purchases on its public listing. Vademecum de medicamentos does not appear to offer in-app purchases. Monetization model: Squeezy runs "Paid app ($4.99)", Vademecum de medicamentos runs "Paid app ($4.99)".
Which has better ratings, Squeezy or Vademecum de medicamentos? v
Squeezy edges ahead with a higher overall score (gap of 4.8 stars). Rating volume: Squeezy 247 ratings, Vademecum de medicamentos 0 ratings. Higher rating volume = stronger ASO signal even when star averages are close.
How accurate are these Squeezy vs Vademecum de medicamentos revenue estimates? v
Directional - typically within 2-3× of actual money earned for popular apps. The $1.6K for Squeezy and $0 for Vademecum de medicamentos are derived from App Store grossing rank, scraped IAP tiers, ratings volume and category benchmarks (Medical) - net of the 15-30% Apple/Google store cut. Real revenue depends on country mix, retention, refunds and ad fill rate, none of which Apple or Google publish.
How do I compare Squeezy or Vademecum de medicamentos to a different App Store app? v
Use the search box at the bottom of this page or paste any two App Store links into the homepage tool. We auto-generate a permanent comparison URL with revenue, downloads, IAP tiers, subscription pricing and grossing rank for both apps.